Aslan:ASLAN Pharmaceuticals Limited (ASLN) Stock Price

ASLAN Pharmaceuticals Limited (ASLN) Stock Price

ASLAN Pharmaceuticals Limited (ASLN) Stock Price

FindthelatestASLANPharmaceuticalsLimited(ASLN)stockquote,history,newsandothervitalinformationtohelpyouwithyourstocktradingand ...。其他文章還包含有:「ASLANPharmaceuticalsLimited(ASLN)股價」、「ASLANPharmaceuticalsLimited(ASLN)走勢圖」、「AslanPharmaceuticalsLtd(ASLN)財報分析和股票健診」、「AslanPharmaceuticals(ASLN)_個股概要」、「ASLANPharmaceuticals」、「ASLN-ASLANPharmaceuticalsLtd-ADR-市場...

查看更多 離開網站

Provide From Google
ASLAN Pharmaceuticals Limited (ASLN) 股價
ASLAN Pharmaceuticals Limited (ASLN) 股價

https://hk.finance.yahoo.com

ASLN - ASLAN Pharmaceuticals Limited. NasdaqCM - NasdaqCM 即時價格。貨幣為USD。 2.8400. +0.0500 (+1.79%). 收市:04:00PM EDT. 2.7500 -0.09 (-3.17%)

Provide From Google
ASLAN Pharmaceuticals Limited(ASLN) 走勢圖
ASLAN Pharmaceuticals Limited(ASLN) 走勢圖

https://tw.stock.yahoo.com

ASLAN Pharmaceuticals Limited · 成交2.8400 · 開盤3.1800 · 最高3.1800 · 最低2.7700 · 一年內最高4.9450 · 買進2.42 · EPS (TTM)-4.0000 · PE Ratio(TTM). - ...

Provide From Google
Aslan Pharmaceuticals Ltd (ASLN) 財報分析和股票健診
Aslan Pharmaceuticals Ltd (ASLN) 財報分析和股票健診

https://statementdog.com

ASLAN Pharmaceuticals Limited於2014年6月在開曼群島註冊成立。該公司是一家專注於臨床階段免疫學的生物製藥公司,致力於開發創新療法,以改變患者的生活。

Provide From Google
Aslan Pharmaceuticals(ASLN)_個股概要
Aslan Pharmaceuticals(ASLN)_個股概要

https://www.futunn.com

提供今日Aslan Pharmaceuticals(ASLN)行情資料,包括價格,各週期走勢圖,基本資料及即時新聞資訊,財務分析,公司介紹,分紅派息資訊,您還可使用富途牛牛開戶 ...

Provide From Google
ASLAN Pharmaceuticals
ASLAN Pharmaceuticals

https://aslanpharma.com

ASLAN Pharmaceuticals is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients.

Provide From Google
ASLN - ASLAN Pharmaceuticals Ltd - ADR - 市場
ASLN - ASLAN Pharmaceuticals Ltd - ADR - 市場

https://invest.cnyes.com

鉅亨美股頻道提供你最完整的ASLN - ASLAN Pharmaceuticals Ltd - ADR 、美股公司資料、美股股票代號、美股新聞、股價走勢、技術線圖、財報分析、外資分析師評等、歷史 ...

Provide From Google
ASLN
ASLN

https://www.moneydj.com

亞獅康股份有限公司(6497.TW,ASLN.US)營運總部位於新加坡,聚焦於癌症標靶藥物與免疫療法之新藥開發,並在台灣、中國及澳洲形成跨區域平台。公司專注於腫瘤領域,授權引進 ...